Enterprise Automation Intern at Eli Lilly and Company

Hyderabad, Telangana, India

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

Pursuing a Bachelor’s in Computer Science, Information Technology, or related fields
Basic programming knowledge (e.g., Python, JavaScript, Automation tools)
Interest in automation technologies and digital transformation
Good communication and teamwork skills
Willingness to learn and adapt in a fast-paced environment

Responsibilities

Support development of automation workflows using tools like AA, Power Automate, and Python
Assist in testing and deploying automation solutions
Document processes and learnings for internal knowledge sharing
Participate in Agile team activities and contribute to sprint goals
Collaborate with cross-functional teams to understand business needs and propose automation ideas

Skills

Automation Anywhere

Power Automate

Python

JavaScript

Agile

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free